Skip to main content
PMC home page
The Journal of Experimental Medicine logoLink to The Journal of Experimental Medicine
. 1991 Jan 1;173(1):65–78. doi: 10.1084/jem.173.1.65

Human platelet-mediated cytotoxicity against Toxoplasma gondii: role of thromboxane

PMCID: PMC2118765  PMID: 1898664

Abstract

Human platelets, in the absence of antibody, are cytotoxic to tachyzoites of Toxoplasma gondii as determined by vital staining, transmission electron microscopy, and the failure of Toxoplasma to survive and replicate in mice after in vitro interaction of the organisms with platelets. Platelet to T. gondii ratios as low as 1:3 were toxic to the organisms with direct cell-cell contact essential for platelet-mediated cytotoxicity. Adherence of platelets to T. gondii and disruption of surface membranes and cytoplasmic contents of the organisms were observed ultrastructurally. Reactive oxygen species were not implicated in the platelet-mediated toxicity. The interaction of T. gondii with platelets resulted in a marked increase in thromboxane B2 (TXB2) production compared with that by unstimulated platelets. The cyclooxygenase inhibitors acetylsalicylic acid and indomethacin inhibited platelet-mediated cytolytic activity as did the selective TXA2 synthetase inhibitor dazmegrel, indicating a role for thromboxane in the platelet-induced cytotoxicity. Further, toxoplasmacidal activity was retained in the TXA2 synthetase-containing microsomal fractions of platelets disrupted by freezing and thawing; cytolytic activity was absent in microsome-depleted platelet supernatant fractions. Both the TXA2-generating platelet microsome system and a stable TXA2 analogue induced damage to the cellular membranes of the Toxoplasma as noted by transmission electron microscopy. These findings suggest that platelets may play a role in the host defense against Toxoplasma and that release of thromboxane may be important in this cytolytic process.

Full Text

The Full Text of this article is available as a PDF (1.6 MB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Anderson S. E., Jr, Bautista S. C., Remington J. S. Specific antibody-dependent killing of Toxoplasma gondii by normal macrophages. Clin Exp Immunol. 1976 Dec;26(3):375–380. [PMC free article] [PubMed] [Google Scholar]
  2. Anderson S. E., Jr, Remington J. S. Effect of normal and activated human macrophages on Toxoplasma gondii. J Exp Med. 1974 May 1;139(5):1154–1174. doi: 10.1084/jem.139.5.1154. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Bout D., Joseph M., Pontet M., Vorng H., Deslée D., Capron A. Rat resistance to schistosomiasis: platelet-mediated cytotoxicity induced by C-reactive protein. Science. 1986 Jan 10;231(4734):153–156. doi: 10.1126/science.3079916. [DOI] [PubMed] [Google Scholar]
  4. Cross P. E., Dickinson R. P., Parry M. J., Randall M. J. Selective thromboxane synthetase inhibitors. 2. 3-(1H-imidazol-1-ylmethyl)-2-methyl-1H-indole-1-propanoic acid and analogues. J Med Chem. 1986 Mar;29(3):342–346. doi: 10.1021/jm00153a007. [DOI] [PubMed] [Google Scholar]
  5. Deem R. L., Britvan L. J., Targan S. R. Definition of a secondary target cell trigger during natural killer cell cytotoxicity: possible role of phospholipase A2. Cell Immunol. 1987 Dec;110(2):253–264. doi: 10.1016/0008-8749(87)90121-3. [DOI] [PubMed] [Google Scholar]
  6. Fusco A. C., Salafsky B., Kevin M. B. Schistosoma mansoni: eicosanoid production by cercariae. Exp Parasitol. 1985 Feb;59(1):44–50. doi: 10.1016/0014-4894(85)90055-4. [DOI] [PubMed] [Google Scholar]
  7. Geissler F. T., Henderson W. R. Inability of aflatoxin B1 to stimulate arachidonic acid metabolism in human polymorphonuclear and mononuclear leukocytes. Carcinogenesis. 1988 Jul;9(7):1135–1138. doi: 10.1093/carcin/9.7.1135. [DOI] [PubMed] [Google Scholar]
  8. Geissler F. T., Kuzan F. B., Faustman E. M., Henderson W. R., Jr Lipid mediator production by post-implantation rat embryos in vitro. Prostaglandins. 1989 Aug;38(2):145–155. doi: 10.1016/0090-6980(89)90078-6. [DOI] [PubMed] [Google Scholar]
  9. Gulbis E., Marion A. M., Dumont J. E., Schell-Frederick E. Prostaglandin formation in bacteria. Prostaglandins. 1979 Sep;18(3):397–400. doi: 10.1016/s0090-6980(79)80058-1. [DOI] [PubMed] [Google Scholar]
  10. Hamberg M., Svensson J., Samuelsson B. Thromboxanes: a new group of biologically active compounds derived from prostaglandin endoperoxides. Proc Natl Acad Sci U S A. 1975 Aug;72(8):2994–2998. doi: 10.1073/pnas.72.8.2994. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Hammarström S., Falardeau P. Resolution of prostaglandin endoperoxide synthase and thromboxane synthase of human platelets. Proc Natl Acad Sci U S A. 1977 Sep;74(9):3691–3695. doi: 10.1073/pnas.74.9.3691. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Henderson W. R., Chi E. Y., Klebanoff S. J. Eosinophil peroxidase-induced mast cell secretion. J Exp Med. 1980 Aug 1;152(2):265–279. doi: 10.1084/jem.152.2.265. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Ibele G. M., Kay N. E., Johnson G. J., Jacob H. S. Human platelets exert cytotoxic effects on tumor cells. Blood. 1985 May;65(5):1252–1255. [PubMed] [Google Scholar]
  14. Jones T. C., Hirsch J. G. The interaction between Toxoplasma gondii and mammalian cells. II. The absence of lysosomal fusion with phagocytic vacuoles containing living parasites. J Exp Med. 1972 Nov 1;136(5):1173–1194. doi: 10.1084/jem.136.5.1173. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Joseph M., Auriault C., Capron A., Vorng H., Viens P. A new function for platelets: IgE-dependent killing of schistosomes. Nature. 1983 Jun 30;303(5920):810–812. doi: 10.1038/303810a0. [DOI] [PubMed] [Google Scholar]
  16. Kettner C., Shaw E. D-Phe-Pro-ArgCH2C1-A selective affinity label for thrombin. Thromb Res. 1979;14(6):969–973. doi: 10.1016/0049-3848(79)90014-8. [DOI] [PubMed] [Google Scholar]
  17. Kocsis J. J., Hernandovich J., Silver M. J., Smith J. B., Ingerman C. Duration of inhibition of platelet prostaglandin formation and aggregation by ingested aspirin or indomethacin. Prostaglandins. 1973 Feb;3(2):141–144. doi: 10.1016/0090-6980(73)90081-6. [DOI] [PubMed] [Google Scholar]
  18. Lefer A. M., Smith E. F., 3rd, Araki H., Smith J. B., Aharony D., Claremon D. A., Magolda R. L., Nicolaou K. C. Dissociation of vasoconstrictor and platelet aggregatory activities of thromboxane by carbocyclic thromboxane A2, a stable analog of thromboxane A2. Proc Natl Acad Sci U S A. 1980 Mar;77(3):1706–1710. doi: 10.1073/pnas.77.3.1706. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Leid R. W., McConnell L. A. PGE2 generation and release by the larval stage of the cestode, taenia taeniaeformis. Prostaglandins Leukot Med. 1983 Jul;11(3):317–323. doi: 10.1016/0262-1746(83)90043-4. [DOI] [PubMed] [Google Scholar]
  20. Leid R. W., McConnell L. A. Thromboxane A2 generation by the larval cestode, Taenia taeniaeformis. Clin Immunol Immunopathol. 1983 Jul;28(1):67–76. doi: 10.1016/0090-1229(83)90189-7. [DOI] [PubMed] [Google Scholar]
  21. Locksley R. M., Fankhauser J., Henderson W. R. Alteration of leukotriene release by macrophages ingesting Toxoplasma gondii. Proc Natl Acad Sci U S A. 1985 Oct;82(20):6922–6926. doi: 10.1073/pnas.82.20.6922. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Marcus A. J., Silk S. T., Safier L. B., Ullman H. L. Superoxide production and reducing activity in human platelets. J Clin Invest. 1977 Jan;59(1):149–158. doi: 10.1172/JCI108613. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Mills E. L., Gerrard J. M., Filipovich D., White J. D., Quie P. G. The chemiluminescence response of human platelets. J Clin Invest. 1978 Mar;61(3):807–814. doi: 10.1172/JCI108995. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Murray H. W., Cohn Z. A. Macrophage oxygen-dependent antimicrobial activity. I. Susceptibility of Toxoplasma gondii to oxygen intermediates. J Exp Med. 1979 Oct 1;150(4):938–949. doi: 10.1084/jem.150.4.938. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Murray H. W., Rubin B. Y., Carriero S. M., Harris A. M., Jaffee E. A. Human mononuclear phagocyte antiprotozoal mechanisms: oxygen-dependent vs oxygen-independent activity against intracellular Toxoplasma gondii. J Immunol. 1985 Mar;134(3):1982–1988. [PubMed] [Google Scholar]
  26. Needleman P., Moncada S., Bunting S., Vane J. R., Hamberg M., Samuelsson B. Identification of an enzyme in platelet microsomes which generates thromboxane A2 from prostaglandin endoperoxides. Nature. 1976 Jun 17;261(5561):558–560. doi: 10.1038/261558a0. [DOI] [PubMed] [Google Scholar]
  27. Pancre V., Joseph M., Mazingue C., Wietzerbin J., Capron A., Auriault C. Induction of platelet cytotoxic functions by lymphokines: role of interferon-gamma. J Immunol. 1987 Jun 15;138(12):4490–4495. [PubMed] [Google Scholar]
  28. Pancré V., Cesbron J. Y., Auriault C., Joseph M., Chandenier J., Capron A. IgE-dependent killing of Brugia malayi microfilariae by human platelets and its modulation by T cell products. Int Arch Allergy Appl Immunol. 1988;85(4):483–486. doi: 10.1159/000234556. [DOI] [PubMed] [Google Scholar]
  29. Pick E., Mizel D. Rapid microassays for the measurement of superoxide and hydrogen peroxide production by macrophages in culture using an automatic enzyme immunoassay reader. J Immunol Methods. 1981;46(2):211–226. doi: 10.1016/0022-1759(81)90138-1. [DOI] [PubMed] [Google Scholar]
  30. Purdon A. D., Patelunas D., Smith J. B. Evidence for the release of arachidonic acid through the selective action of phospholipase A2 in thrombin-stimulated human platelets. Biochim Biophys Acta. 1987 Aug 15;920(3):205–214. doi: 10.1016/0005-2760(87)90096-8. [DOI] [PubMed] [Google Scholar]
  31. Sabin A. B., Feldman H. A. Dyes as Microchemical Indicators of a New Immunity Phenomenon Affecting a Protozoon Parasite (Toxoplasma). Science. 1948 Dec 10;108(2815):660–663. doi: 10.1126/science.108.2815.660. [DOI] [PubMed] [Google Scholar]
  32. Seaman W. E. Human natural killer cell activity is reversibly inhibited by antagonists of lipoxygenation. J Immunol. 1983 Dec;131(6):2953–2957. [PubMed] [Google Scholar]
  33. Sheffield H. G., Melton M. L. The fine structure and reproduction of Toxoplasma gondii. J Parasitol. 1968 Apr;54(2):209–226. [PubMed] [Google Scholar]
  34. Shepp D. H., Hackman R. C., Conley F. K., Anderson J. B., Meyers J. D. Toxoplasma gondii reactivation identified by detection of parasitemia in tissue culture. Ann Intern Med. 1985 Aug;103(2):218–221. doi: 10.7326/0003-4819-103-2-218. [DOI] [PubMed] [Google Scholar]
  35. Slezak S., Symer D. E., Shin H. S. Platelet-mediated cytotoxicity. Role of antibody and C3, and localization of the cytotoxic system in membranes. J Exp Med. 1987 Aug 1;166(2):489–505. doi: 10.1084/jem.166.2.489. [DOI] [PMC free article] [PubMed] [Google Scholar]
  36. Smith E. F., 3rd, Lefer A. M., Aharony D., Smith J. B., Magolda R. L., Claremon D., Nicolaou K. C. Carbocyclic thromboxane A2: aggrevation of myocardial ischemia by a new synthetic thromboxane A2 analog. Prostaglandins. 1981 Mar;21(3):443–456. doi: 10.1016/0090-6980(81)90090-3. [DOI] [PubMed] [Google Scholar]
  37. Soper W. D., Bartlett S. P., Winn H. J. Lysis of antibody-coated cells by platelets. J Exp Med. 1982 Oct 1;156(4):1210–1221. doi: 10.1084/jem.156.4.1210. [DOI] [PMC free article] [PubMed] [Google Scholar]
  38. Suzuki Y., Orellana M. A., Schreiber R. D., Remington J. S. Interferon-gamma: the major mediator of resistance against Toxoplasma gondii. Science. 1988 Apr 22;240(4851):516–518. doi: 10.1126/science.3128869. [DOI] [PubMed] [Google Scholar]
  39. Tripp C. S., Leahy K. M., Needleman P. Thromboxane synthase is preferentially conserved in activated mouse peritoneal macrophages. J Clin Invest. 1985 Aug;76(2):898–901. doi: 10.1172/JCI112051. [DOI] [PMC free article] [PubMed] [Google Scholar]
  40. Tripp C. S., Needleman P., Unanue E. R. Indomethacin in vivo increases the sensitivity to Listeria infection in mice. A possible role for macrophage thromboxane A2 synthesis. J Clin Invest. 1987 Feb;79(2):399–403. doi: 10.1172/JCI112825. [DOI] [PMC free article] [PubMed] [Google Scholar]
  41. Villa M. L., Valenti F., Mantovani M. Modulation of natural killing by cyclo- and lipo-oxygenase inhibitors. Immunology. 1988 Jan;63(1):93–97. [PMC free article] [PubMed] [Google Scholar]
  42. Wilson C. B., Remington J. S. Activity of human blood leukocytes against Toxoplasma gondii. J Infect Dis. 1979 Dec;140(6):890–895. doi: 10.1093/infdis/140.6.890. [DOI] [PubMed] [Google Scholar]
  43. Wörner P. Arachidonic acid-induced chemiluminescence of human platelets: contribution of the prostaglandin and lipoxygenase pathways. Thromb Haemost. 1981 Oct;46(3):584–589. [PubMed] [Google Scholar]

Articles from The Journal of Experimental Medicine are provided here courtesy of The Rockefeller University Press

RESOURCES